Stephen Curry won two NBA titles and two MVP awards while quietly battling blurred vision from a rare eye disease nobody had caught yet.
Story Snapshot
- Curry has partnered with medical company Glaukos to launch “Could it be KC?”, a campaign to raise awareness of keratoconus, a progressive eye disease.
- Curry says he lived with blurred vision for years during the Warriors’ championship run before doctors diagnosed the condition.
- The campaign includes a children’s picture book, “Eye on the Ball,” and a community event with students in Oakland, California.
- Glaukos plans to expand the awareness push into 2027, with a focus on catching the disease early in kids and teens.
A Star’s Vision Problem Nobody Saw Coming
Glaukos Corporation announced the campaign on September 23, 2026, calling it “a new disease awareness and educational campaign” built to improve recognition and earlier detection of keratoconus. The company named Curry as its partner and said he would “share his personal experience living with KC to help elevate awareness and bring greater visibility to the disease”. That is a direct, specific commitment, not a vague celebrity shout-out.
Curry has described the diagnosis in blunt terms. “They told me that I had a rare condition called Keratoconus,” he said, recalling how the news landed during his career with the Golden State Warriors. Keratoconus thins and reshapes the cornea, blurring vision gradually. For an athlete whose entire livelihood depends on tracking a ball at high speed, that is not a small inconvenience. It is a threat to the job itself.
Winning Titles While Fighting Blurred Sight
What makes Curry’s story land is the timing. He built his reputation as basketball’s greatest shooter while his eyesight was working against him. Reports say his condition went undiagnosed for years, even as he collected championship rings and MVP trophies. He now wants other people to skip that long stretch of not knowing, urging fans to “go get checked” and start real conversations with eye doctors.
Glaukos built the campaign around exactly that gap between symptoms and diagnosis. The company says its outreach targets “individuals, families, caregivers, and healthcare providers,” aiming to help people “recognize potential warning signs” and push for earlier diagnosis. That is a sensible goal. Waiting years to name a treatable condition helps no one, whether you play in the NBA or drive a school bus.
Why Kids Are the Real Target Audience
The campaign leans hard into youth outreach, and there is a medical reason for that. Keratoconus tends to progress faster in younger patients, making early screening more urgent for children and teens than for older adults. Curry joined students in Oakland for a community event centered on eye health, turning the announcement into an actual outreach activity rather than a press release stunt.
The campaign also includes a picture book, “Eye on the Ball,” inspired by Curry’s own journey and aimed at schools, eye care offices, and libraries. Putting a children’s book alongside a corporate health campaign is an unusual move, but it fits the stated goal: reaching kids before symptoms quietly worsen for years, the way Curry’s did.
Golden State Warriors Stephen Curry, widely regarded as the greatest shooter in basketball history, discusses his journey with keratoconus, a progressive eye disorder. https://t.co/qojy9tzDQ9
— Arnaud Mercier – #Entrepreneur #Versailles (@arnaudmercier) September 24, 2026
A Corporate Partner With Skin in the Game
Glaukos is not a neutral public health agency. It is an ophthalmic pharmaceutical and medical technology company with its own commercial stake in eye disease treatment. That does not make the awareness message false. It does mean readers should understand the campaign is branded marketing built on a real medical story, not a government health initiative. Both things can be true at once.
Disease-awareness campaigns run by drug and device makers have long drawn extra scrutiny for exactly this reason: they can shape how the public understands a condition before a patient ever sees a doctor. That is not a knock on Curry’s honesty about his own experience. It is simply the reality of how modern health marketing works, and readers deserve to see that context plainly.
Glaukos says the campaign will keep expanding through 2027, signaling this is meant to be an ongoing effort rather than a one-week publicity cycle. For a disease that can quietly damage vision over years, as it apparently did for one of basketball’s biggest stars, a sustained push toward earlier eye exams is hard to argue against.
Sources:
thelooker.thedailybeast.com, nbcsportsbayarea.com, sports.yahoo.com, forbes.com, yardbarker.com, businesswire.com
